UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma

Cell reports (Cambridge), 2021-07, Vol.36 (4), p.109455-109455, Article 109455

2021

Volltextzugriff (PDF)

Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series

Neurological sciences, 2020-08, Vol.41 (8), p.2111-2120

2020

Volltextzugriff (PDF)

Mutations targeting the coagulation pathway are enriched in brain metastases

Scientific reports, 2017-07, Vol.7 (1), p.6573-6, Article 6573

2017

Volltextzugriff (PDF)

MNGI-07. TRIMETHYLATED H3K27 AND EZH2 EXPRESSION IN MENINGIOMA: CORRELATION WITH TENDENCY TO RECUR

Neuro-oncology (Charlottesville, Va.), 2019-11, Vol.21 (Supplement_6), p.vi140-vi140

2019

Volltextzugriff (PDF)

EPCO-02. GENOME-WIDE DNA METHYLATION PROFILING AND GENETIC CHARACTERIZATION OF LONG-TERM SURVIVAL IDH WILD-TYPE GLIOBLASTOMA PATIENTS

Neuro-oncology (Charlottesville, Va.), 2022-11, Vol.24 (Supplement_7), p.vii115-vii116

2022

Volltextzugriff (PDF)

CTIM-26. IMPACT ON SURVIVAL OF INTERFERON-ALPHA DELIVERY IN GLIOBLASTOMA WITH UNMETHYLATED MGMT BY IMMUNO-GENE THERAPY WITH TEMFERON

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v68-v68

2023

Volltextzugriff (PDF)

PATH-31. GIANT CELL GLIOBLASTOMAS: ANALYSIS OF MISMATCH-REPAIR (MMR) PROTEINS EXPRESSION, POLIMERASE ε (POLE) MUTATIONS AND THEIR ROLE IN TUMOR IMMUNORESPONSE

Neuro-oncology (Charlottesville, Va.), 2018-11, Vol.20 (suppl_6), p.vi165-vi165

2018

Volltextzugriff (PDF)

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

Blood, 2021-11, Vol.138 (Supplement 1), p.2844-2844

2021

Volltextzugriff (PDF)

Abstract B007: Establishment of patient-derived brain metastasis initiating cells as a novel preclinical model of breast cancer metastatization

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (5_Supplement_1), p.B007-B007

2024

Volltextzugriff (PDF)

CTIM-19. TEM-GBM: A PHASE I-IIA DOSE-ESCALATION STUDY DELIVERING IFN-Α WITHIN GLIOBLASTOMA MULTIFORME TUMOR MICROENVIRONMENT BY GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi54-vi54

2021

Volltextzugriff (PDF)

Abstract 4694: Single-cell analysis of glioblastoma immune contexture identifies a subset of activated and memory tumor-reactive CD8+ TILs and a Treg signature contributing to TIL irreversible dysfunction

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.4694-4694

2023

Volltextzugriff (PDF)

ME-16IS AQUAPORIN4 (AQP4) INVOLVED IN ADULT HUMAN MEDULLOBLASTOMA DISSEMINATION OR IN A BENEFICIAL BARRIER FORMATION?

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (Suppl 5), p.v123-v123

2014

Volltextzugriff (PDF)

MPTH-28STUDY OF THE ROLE OF IFI-16 EXPRESSION IN GLIOMAS

Neuro-oncology (Charlottesville, Va.), 2015-11, Vol.17 (suppl 5), p.v144.3-v144

2015

Volltextzugriff (PDF)

CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109)

Neuro-oncology advances, 2022-08, Vol.4 (Supplement_1), p.i7-i7

2022

Volltextzugriff (PDF)

Abstract 942: ErbB3 overexpression unleashed by miR-205 epigenetic silencing is a therapeutic target in glioblastoma

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.942-942

2021

Volltextzugriff (PDF)

The Search for Molecular Markers in a Gene-Orphan Case Study of a Pediatric Spinal Cord Pilocytic Astrocytoma

Cancer genomics & proteomics, 2020-03, Vol.17 (2), p.117-130

2020

Volltextzugriff (PDF)

ME-16 IS AQUAPORIN4 (AQP4) INVOLVED IN ADULT HUMAN MEDULLOBLASTOMA DISSEMINATION OR IN A BENEFICIAL BARRIER FORMATION?

Neuro-oncology (Charlottesville, Va.), 2014-11, Vol.16 (suppl 5), p.v123-v123

2014

Volltextzugriff (PDF)

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresResearch in context

EBioMedicine, 2019-09, Vol.47, p.33-43

2019

Volltextzugriff (PDF)

IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT

Neuro-oncology advances, 2021-09, Vol.3 (Supplement_4), p.iv4-iv4

2021

Volltextzugriff (PDF)

[OA109] Validation of a radio-guided surgery technique based on beta-radiation: Test on ex-vivo specimens

Physica medica, 2018-08, Vol.52, p.42-42

2018

Volltextzugriff (PDF)

No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science

Journal of clinical medicine, 2020-05, Vol.9 (5), p.1472

2020

Volltextzugriff (PDF)

Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers and neonates at birth

American journal of obstetrics & gynecology MFM, 2020-08, Vol.2 (3), p.100145-100145, Article 100145

2020

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Aktive Filter

KollektionWiley Online Library - AutoHoldings Journals

Zeitschrift / SerieCancers

ThemaAnimals

ThemaMiddle Aged

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(32)

Publikationsform

Artikel
(34)
Bücher
(1)
Berichte
(1)

Sprache

Englisch
(36)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

ERBB3 overexpression due to miR-205 inactivation confers sensitivity to FGF, metabolic activation, and liability to ERBB3 targeting in glioblastoma

Gliomatosis cerebri (GC) or GC-like? A picture to be reconsidered in neuro-oncology based on large retrospective analysis of GC series

Clinicopathological and molecular landscape of 5-year IDH-wild-type glioblastoma survivors: A multicentric retrospective study

Mutations targeting the coagulation pathway are enriched in brain metastases

MNGI-07. TRIMETHYLATED H3K27 AND EZH2 EXPRESSION IN MENINGIOMA: CORRELATION WITH TENDENCY TO RECUR

EPCO-02. GENOME-WIDE DNA METHYLATION PROFILING AND GENETIC CHARACTERIZATION OF LONG-TERM SURVIVAL IDH WILD-TYPE GLIOBLASTOMA PATIENTS

CTIM-26. IMPACT ON SURVIVAL OF INTERFERON-ALPHA DELIVERY IN GLIOBLASTOMA WITH UNMETHYLATED MGMT BY IMMUNO-GENE THERAPY WITH TEMFERON

Reprogramming Macrophages Using Autologous Hematopoietic Stem Cells As Immunotherapy for Glioblastoma: TEM-GBM Study (NCT03866109)

PATH-31. GIANT CELL GLIOBLASTOMAS: ANALYSIS OF MISMATCH-REPAIR (MMR) PROTEINS EXPRESSION, POLIMERASE ε (POLE) MUTATIONS AND THEIR ROLE IN TUMOR IMMUNORESPONSE

TEM-GBM: An Open-Label, Phase I/IIa Dose-Escalation Study Evaluating the Safety and Efficacy of Genetically Modified Tie-2 Expressing Monocytes to Deliver IFN-α within Glioblastoma Tumor Microenvironment

Abstract B007: Establishment of patient-derived brain metastasis initiating cells as a novel preclinical model of breast cancer metastatization

CTIM-19. TEM-GBM: A PHASE I-IIA DOSE-ESCALATION STUDY DELIVERING IFN-Α WITHIN GLIOBLASTOMA MULTIFORME TUMOR MICROENVIRONMENT BY GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES

Abstract 4694: Single-cell analysis of glioblastoma immune contexture identifies a subset of activated and memory tumor-reactive CD8+ TILs and a Treg signature contributing to TIL irreversible dysfunction

ME-16IS AQUAPORIN4 (AQP4) INVOLVED IN ADULT HUMAN MEDULLOBLASTOMA DISSEMINATION OR IN A BENEFICIAL BARRIER FORMATION?

MPTH-28STUDY OF THE ROLE OF IFI-16 EXPRESSION IN GLIOMAS

CLRM-08 TARGETING IMMUNE-PAYLOAD TO THE GLIOBLASTOMA TUMOR MICROENVIRONMENT USING A MACROPHAGE-BASED TREATMENT RELYING ON AUTOLOGOUS, GENETICALLY MODIFIED, HEMATOPOIETIC STEM CELL-BASED THERAPY: THE TEM-GBM STUDY (NCT03866109)

Abstract 5213: Genetically modified Tie-2 expressing monocytes target IFN-α2 to the glioblastoma tumor microenvironment (TME): Preliminary data from the TEM-GBM Phase 1/2a study

Abstract 942: ErbB3 overexpression unleashed by miR-205 epigenetic silencing is a therapeutic target in glioblastoma

The Search for Molecular Markers in a Gene-Orphan Case Study of a Pediatric Spinal Cord Pilocytic Astrocytoma

ME-16 IS AQUAPORIN4 (AQP4) INVOLVED IN ADULT HUMAN MEDULLOBLASTOMA DISSEMINATION OR IN A BENEFICIAL BARRIER FORMATION?

B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheresResearch in context

IMMU-01. TEM-GBM: AN OPEN-LABEL, PHASE I/IIA DOSE-ESCALATION STUDY EVALUATING THE SAFETY AND EFFICACY OF GENETICALLY MODIFIED TIE-2 EXPRESSING MONOCYTES TO DELIVER IFN-A WITHIN GLIOBLASTOMA TUMOR MICROENVIRONMENT

[OA109] Validation of a radio-guided surgery technique based on beta-radiation: Test on ex-vivo specimens

No Autopsies on COVID-19 Deaths: A Missed Opportunity and the Lockdown of Science

Vertical transmission of coronavirus disease 2019: severe acute respiratory syndrome coronavirus 2 RNA on the fetal side of the placenta in pregnancies with coronavirus disease 2019–positive mothers and neonates at birth

Aktive Filter

Suchergebnisse filtern